160 related articles for article (PubMed ID: 11081447)
21. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
22. Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease.
Hoshiga M; Arishiro K; Nakakoji T; Miyazaki N; Negoro N; Okabe T; Kohbayashi E; Ishihara T; Hanafusa T
J Atheroscler Thromb; 2010 Jul; 17(7):705-11. PubMed ID: 20065610
[TBL] [Abstract][Full Text] [Related]
23. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
[TBL] [Abstract][Full Text] [Related]
24. [The effect of a reduction in plasma cholesterol on the evolution of coronary disease].
Fernández-Avilés F; García-Morán E
Rev Esp Cardiol; 1995; 48 Suppl 5():43-51. PubMed ID: 7494940
[TBL] [Abstract][Full Text] [Related]
25. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
[TBL] [Abstract][Full Text] [Related]
27. Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
Colquhoun DM
Aust Fam Physician; 2002 Jan; 31(1):25-6, 29-30. PubMed ID: 11840884
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP
Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332
[TBL] [Abstract][Full Text] [Related]
29. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
30. Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction.
Walter DH; Fichtlscherer S; Britten MB; Auch-Schwelk W; Schächinger V; Zeiher AM
Am J Cardiol; 2002 Jan; 89(1):1-6. PubMed ID: 11779513
[TBL] [Abstract][Full Text] [Related]
31. The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
Plana JC; Jones PH
Curr Atheroscler Rep; 2001 Sep; 3(5):355-64. PubMed ID: 11487446
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic effects and cholesterol-lowering therapy.
Shaw SM; Fildes JE; Yonan N; Williams SG
Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
[TBL] [Abstract][Full Text] [Related]
33. Effects of statin therapy on vascular dysfunction.
Aikawa M
Coron Artery Dis; 2004 Aug; 15(5):227-33. PubMed ID: 15238817
[TBL] [Abstract][Full Text] [Related]
34. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
Ghali JK
Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
[No Abstract] [Full Text] [Related]
35. Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy.
Kinlay S; Ganz P
Am J Cardiol; 2000 Oct; 86(8B):10J-13J; discussion 13J-14J. PubMed ID: 11081444
[TBL] [Abstract][Full Text] [Related]
36. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials.
Bavry AA; Mood GR; Kumbhani DJ; Borek PP; Askari AT; Bhatt DL
Am J Cardiovasc Drugs; 2007; 7(2):135-41. PubMed ID: 17503884
[TBL] [Abstract][Full Text] [Related]
37. More than cholesterol: the complexity of coronary artery disease.
Ijem J; Granlie C
S D J Med; 2000 Nov; 53(11):489-91. PubMed ID: 11098718
[TBL] [Abstract][Full Text] [Related]
38. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
[TBL] [Abstract][Full Text] [Related]
39. Early initiation of statin therapy in acute coronary syndromes: a review of the evidence.
Rondina MT; Muhlestein JB
J Interv Cardiol; 2005 Feb; 18(1):55-63. PubMed ID: 15788056
[TBL] [Abstract][Full Text] [Related]
40. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
